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High-throughput identification of small mole-
cules that selectivelymodulatemolecular, cellu-
lar, or systems-level properties of the mamma-
lian brain is a significant challenge. Here we
report the chemical genetic identification of the
orphan ligand phosphoserine (P-Ser) as an en-
hancer of neurogenesis. P-Ser inhibits neural
stem cell/progenitor proliferation and self-re-
newal, enhances neurogenic fate commitment,
and improves neuronal survival. We further
demonstrate that the effects of P-Ser are medi-
ated by the group III metabotropic glutamate
receptor 4 (mGluR4). siRNA-mediated knock-
down of mGluR4 abolished the effects of P-Ser
and increased neurosphere proliferation, at
least in part through upregulation of mTOR
pathway activity. We also found that P-Ser in-
creasesneurogenesis inhumanembryonicstem
cell-derived neural progenitors. This work high-
lights the tremendous potential of developing
effective small-molecule drugs for use in regen-
erative medicine or transplantation therapy.
INTRODUCTION
The use of small-molecule probes in biological studies
has a long, rich history. Such compounds, though often
found by chance, are increasingly sought after using
high-throughput screening (HTS) efforts [1]. Complicated
experimental systems, such as the mammalian brain, re-
main recalcitrant to systematic approaches [2, 3]. Poten-
tially, cell-based chemical genetic screens, which can be
used to identify compounds that produce a phenotype of
interest, provide a simple, rapid, and content-rich format
for identifying such small molecules [4].
Neural stem cells (NSCs) have the capacity to self-
renew and ultimately produce the three major cell typesChemistry & Biology 14, 1019–1030,of the brain, namely neurons, astrocytes, and oligoden-
drocytes. The discovery of neural stem cells has tremen-
dous importance not only for understanding the genera-
tion of this cellular diversity but also has vast practical
implications for repair of the central nervous system
(CNS) following injury. The initial isolation of neural stem
cells has led to large, systematic efforts to identify andma-
nipulate molecular mechanisms of NSC proliferation, cell-
fate determination, and differentiation. Although many of
the genetic and biochemical pathways underlying these
processes are beginning to be understood, currently there
are few known small-molecule probes for specifically
studying and controlling these mechanisms.
The need for such tools has been recognized for some
time (reviewed in [5]), and previous studies have utilized
cell lines to screen for small molecules that specifically
induce differentiation of stem cells of neuroepithelial,
and other, origin [6–8]. However, small-molecule probes
for examining the intricately related processes of stem
cell proliferation and cell-fate choice have remained un-
identified, and the advantages of using primary culture
stem cells have not been exploited. In the current study,
we developed a reliable primary cell screen using neuro-
spheres, ex vivo cultures containing neural stem cells [9].
Neurospheres derived from embryonic day 11.5 (E11.5)
mouse telencephalon were screened against libraries
of bioactive small molecules (following mitogen with-
drawal), including kinase/phosphatase inhibitors and or-
phan ligands (see Experimental Procedures). Using these
primary cultures as a screening platform, we identified
phosphoserine (P-Ser), a member of the orphan ligand
library and an endogenous serine metabolite, as a regula-
tor of neural progenitor proliferation, fate commitment,
and differentiation. Subsequently, we determined that
these effects are mediated through activation of metabo-
tropic glutamate receptor 4 (mGluR4). Broadly, these
studies demonstrate the utility of relatively simple screen-
ing assays for identifying highly useful small-molecule
probes which can be used to elucidate novel roles for
cell-intrinsic and extrinsic factors in neural stem cell
biology.September 2007 ª2007 Elsevier Ltd All rights reserved 1019
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A Phenotypic Screen for NeurogenesisFigure 1. P-Ser Enhances Neuronal Differentiation of Neural Stem Cells
(A) Scheme of small-molecule screen. The scanning electron micrograph (SEM) micrograph is from the embryo images collection at http://www.med.
unc.edu/embryo_images/, used with permission.
(B) Secondary E12.5 spheres differentiated with or without P-Ser and stained for Tuj1 and propidium iodide (PI). The scale bars represent 300 mm.
(C) Neuron counts of differentiated secondary E12.5 spheres, p = 0.0013.
(D) Neuron counts of differentiated secondary P1 cortical spheres, p = 0.0169.
(E) Dose response of P-Ser concentration versus number of neurons generated from differentiated E12.5 spheres. Data are normalized so that
untreated is set to 100%.
(F) RT-PCR analysis of differentiated E12.5 spheres. –RT, no reverse transcriptase control. For densitometry, data are normalized so that untreated is
set to 100%. P-Ser (10 mM) was used in all experiments. Data are represented as mean ± SEM in (C)–(E).RESULTS
Primary neurospheres were passaged one time to expand
the limited amount of startingmaterial and to ensure a self-
renewing progenitor population while minimizing effects
of any differentiated cells that remain after dissection.
Secondary neurospheres were differentiated in 96-well
plates with one library compound per well for 3 days. Cul-
tures were then processed for immunoreactivity against a
commonly used neuron-specificmarker, bIII tubulin (Tuj1),
using chemiluminescent detection (Figure 1A). Approxi-
mately 7%–9% of cells normally differentiate toward a
neuronal lineage and express Tuj1; this assay reliably
detects molecules which enhance expression of this
marker, as shown by the addition of the neurotrophin
brain-derived neurotrophic factor (see Figure S1A in the
Supplemental Data available with this article online). Im-
portantly, this enhancement in Tuj1 immunoreactivity
need not be due to increased neurogenesis; compounds1020 Chemistry & Biology 14, 1019–1030, September 2007 ª20which influence neurite branching or axonal outgrowth
would also register as positive hits. Any potential candi-
dates need to be tested in secondary assays to validate
functional effects on the phenotype of interest.
For the primary screen using Tuj1 immunoreactivity as a
readout, we assayed several hundred bioactive molecules
(including kinase/phosphatase inhibitors and orphan li-
gands; see Experimental Procedures) and identified 64
compounds which were classified into two groups: ‘‘en-
hancers’’ which increased Tuj1 signals, and ‘‘inhibitors’’
which decreased Tuj1 signals (Table S1). Most of the
inhibitors exhibited general cytotoxicity and were not
studied further; others have been described as exerting
negative effects on neuronal function, e.g., p38 MAP
kinase inhibitors [10, 11]. Among the enhancers, several
are known to improve neuronal survival, e.g., tobacco
smoke constituents [12]. Fourteen compounds were cho-
sen for secondary screening, of which five (four enhancers
and one inhibitor; Figures S1B–S1D) were confirmed to07 Elsevier Ltd All rights reserved
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A Phenotypic Screen for Neurogenesismodulate neuronal differentiation. A novel enhancer iden-
tified from the orphan ligand library is L-serine-O-phos-
phate (phosphoserine; P-Ser). P-Ser increased the num-
ber of Tuj1+ cells in differentiating E12.5 cortical cultures
(Figures 1B and 1C) in a dose-dependent manner (Fig-
ure 1E). Similar effects were observed in cultures derived
frommouse postnatal day 1 (P1) cortex (Figure 1D). These
results suggest that the effects of P-Ser are not limited to
a single developmental stage. The increased neuronal
identity of P-Ser-treated cultures was further confirmed
by elevated expression of the neurogenic bHLH transcrip-
tion factor NeuroD in differentiated E12.5 neurospheres,
as determined by RT-PCR (Figure 1F).
The neurogenic phenotype of P-Ser could be due to
effects on progenitor proliferation, cell-fate commitment,
and/or neuronal survival. We first assayed the effects of
P-Ser on progenitor proliferation using the neurosphere
assay. P-Ser treatment of secondary neurospheres (see
below) reduced proliferation, based on cell number mea-
surements (Figure 2A) and neurosphere size (Figure 2B).
This finding was confirmed by a 33% decrease in BrdU
labeling of P-Ser-treated attached progenitor cultures
(Figure 2C).
The findings above could represent an effect on neural
stem cells, other progenitors within the culture, or both.
Therefore, we also analyzed production of new stem cells
during P-Ser treatment. Primary neurospheres can be dis-
sociated and replated, as single cells, to form secondary
neurospheres. Neurospheres form aggregates at cell den-
sities of >5000 cells/ml, which can confound analysis of
the true proliferative potential of the plated cells [13]. In
contrast, at a cell density of 1000 cells/ml, nearly all newly
formed neurospheres are clonal in origin, that is, derived
from a single plated cell [14] (T.K.K. and H.I.K., unpub-
lished observations). Thus, at this cell density, the neu-
rosphere assay can be used as a reliable estimate of
stem cell proliferation (see Discussion). Secondary neuro-
spheres were grown under clonal conditions with or with-
out P-Ser. These spheres were then dissociated to single
cells and allowed to form tertiary neurospheres under
optimal conditions. The number of tertiary neurospheres
formed is a direct measure of stem cell proliferation. We
found that there were fewer tertiary spheres formed from
P-Ser-treated secondary spheres than from control
secondary spheres (Figure 2D). Nearly all spheres were
tripotent, giving rise to neurons, astrocytes, and oligoden-
drocytes (Figure S2A), suggesting that P-Ser inhibits
proliferation of multipotent sphere-forming progenitors.
We next measured the effects of P-Ser on neurogenesis
in proliferating neurospheres. We found that whereas P-
Ser decreased cell number and neurosphere size (Figures
2A and 2B), there was an increase in the percentage of
Tuj1+ cells within the proliferating spheres (Figure 2E; Fig-
ure S2B). Upon differentiation, secondary spheres grown
in P-Ser generated more Tuj1+ cells than control cultures
(Figure 2F). As these P-Ser-treated spheres were pas-
saged continually, the relative percentages of Tuj1+ cells
generated upon differentiation increased compared to
controls (Figure 2G). Furthermore, spheres grown in theChemistry & Biology 14, 1019–103presence of P-Ser contained elevated levels of the neuro-
nal fate-determining bHLH transcription factor Neuroge-
nin2 (Ngn2; Figure 2F), as determined by RT-PCR. To-
gether, these results strongly suggest that P-Ser directly
enhances commitment of NSCs toward a neurogenic
fate.
This possibility was confirmed via clonal analysis. If
P-Ser instructs commitment of NSCs toward a particular
lineage, then tertiary neurospheres derived from treated
secondary spheres should show a predisposition toward
generating that fate. Therefore, secondary neurospheres
were grown at clonal density in the absence or presence
of P-Ser. These neurosphereswere then passaged to form
tertiary neurospheres at clonal density, in the absence of
P-Ser, and subsequently differentiated to determine their
neurogenic capacity.We found thatP-Ser-treated spheres
gave rise to tertiary spheres that were twice as neurogenic
as control-derived tertiary spheres (Figure 2H).
We also tested whether P-Ser affects neuronal survival.
To this end, we derived neuronal cultures from E14.5
mouse cortex, treated with P-Ser or water, and quantified
the neurons at multiple time points. Compared to control
conditions in which the number of Tuj1+ cells with neuro-
nal morphology decreased over time (Figures 3A and
3B), P-Ser treatment caused an increase in the number
of these cells remaining in the cultures at both time points
assayed (Figure 3B). This rescue was especially pro-
nounced by 3 days postplating, suggesting that P-Ser
has neuroprotective effects under these conditions (Fig-
ures 3A and 3B). Consistent with this possibility, P-Ser
treatment resulted in a substantial decrease in the total
number of apoptotic nuclei as indicated by TUNEL assay
(Figures 3A and 3C), in agreement with the percentage of
Tuj1+ cells undergoing apoptosis after 3 days (Figure 3D).
We then investigated potential molecular mechanisms
through which P-Ser could act to modulate these pheno-
types. One possibility is that P-Ser influences the serine
biosynthesis pathway, which has been postulated to be
important for neurogenesis [15, 16]. Another possibility is
that the neurogenic effects of P-Ser may be mediated by
group III metabotropic glutamate receptors, for which
it is an agonist [17]. The latter hypothesis is supported
by our findings that another group III receptor agonist
(L-AP4) [17] produced similar effects as P-Ser on neuro-
sphere size, whereas a group III receptor antagonist
(UBP1112) [18] reversed the effects of P-Ser (Figure 4A).
The effects of these compounds were also observed on
differentiating secondary neurospheres derived from P1
cortex (Figure 4B). Here, treatment with either P-Ser or
L-AP4 caused a >2-fold increase in the number of Tuj1+
cells generated (Figure 4B). UBP1112 again abolished
this increase (Figure 4B). No enhancement of neuronal dif-
ferentiation was observed in E12 neurospheres following
treatment with either 10 mM D-serine-O-phosphate or
D-AP4 (Figure S3A), which are >300-fold less potent for
this class of receptors than their L enantiomers [19, 20].
Thus, group III metabotropic receptors appear to mediate
the effects of P-Ser in both proliferating and differentiating
neurosphere cultures.0, September 2007 ª2007 Elsevier Ltd All rights reserved 1021
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A Phenotypic Screen for NeurogenesisFigure 2. P-Ser Slows Progenitor Proliferation and Enhances Neurogenic Commitment
(A) Cells were plated at 1 k/ml and grown with or without 10 mM P-Ser for 1 week, then trypsinized and counted by trypan blue exclusion, p = 0.0293.
(B) Histogram of clonal neurosphere size after 1 week in culture.
(C) BrdU labeling index; dissociated primary neurospheres were plated on polyornithine-fibronectin-coated coverslips and grown for 4 days with
or without 10 mM P-Ser, then pulsed with 5 mM BrdU for 2 hr and fixed, p = 0.009. The scale bars represent 100 mm.
(D) Number of tertiary clonal neurospheres derived from P-Ser-treated (10 mM) or untreated secondary neurospheres. Data are normalized to
untreated (100%), p = 1.91 3 105.
(E) Analysis of Tuj1+ cells present in acutely dissociated neurospheres grown with or without 10 mM P-Ser, p = 0.00137.
(F) Neurospheres were grown continually with or without 20 mM P-Ser for the indicated number of passages. Neurospheres were then harvested for
RNA for RT-PCR analysis of ngn2 expression, or differentiated and stained for Tuj1, p(2) = 0.0031, p(6) = 0.00031.
(G) Neurospheres were continually grown with or without 20 mM P-Ser over multiple passages. Aliquots of each passage were differentiated and
stained for Tuj1, p(3) = .00295, p(4) = 0.0163, p(5) = 0.0111, p(6) = 0.0075. Multiple comparisons across passages were not made.
(H) Tertiary neurospheres were derived from P-Ser-treated (20 mM) or untreated secondary spheres, differentiated for 5 days, and stained for Tuj1,
p = 2.86 3 105. Data are represented as mean ± SEM in (A) and (D)–(H).1022 Chemistry & Biology 14, 1019–1030, September 2007 ª2007 Elsevier Ltd All rights reserved
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A Phenotypic Screen for NeurogenesisFigure 3. P-Ser Improves Survival in Differentiating Neuron Cultures
(A) Three day old E14.5 cortical neurons cultured with or without 10 mM P-Ser. TUNEL assay (green) was performed on cultures, followed by staining
for Tuj1 (red). The scale bars represent 25 mm.
(B) Number of Tuj1+ cells in 1 or 3 day E14 cortical neuron cultures untreated or with 10 mMP-Ser. 1 dayCtrl versus 1 dayP-Ser, p = 0.0931; 3 dayCtrl
versus 3 dayP-Ser, p = 0.0346; 1 dayCtrl versus 3 dayCtrl, p = 0.0136; 1 dayP-Ser versus 3 dayP-Ser, p = 0.0284.
(C) Number of TUNEL+ cells in 1 or 3 day E14 cortical neuron cultures untreated or with 10 mMP-Ser. 1 dayCtrl versus 1 dayP-Ser, p = 0.0719; 3 dayCtrl
versus 3 dayP-Ser, p = 0.0138; 1 dayCtrl versus 3 dayCtrl, p = 0.025; 1 dayP-Ser versus 3 dayP-Ser, p = 0.1877.
(D) Number of TUNEL+ Tuj1+ double-positive cells as a percentage of total Tuj1+ cells in 3 day E14 cortical neuron cultures untreated or with 10 mM
P-Ser, p = 0.0013. All data are presented as mean ± SEM.In order to examine the physiologically relevant receptor
species, we analyzed the expression of the various mem-
bers of the group III mGluRs by RT-PCR. In primary neuro-
spheres, mGluR7 and 8 were present at very low levels,
whereas mGluR4 was moderately abundant (Figure 4C).
In secondary neurospheres, only mGluR4 was detected
(Figure 4C). The primer sets used were equally capable
of detecting equimolar quantities of appropriate template
in control reactions (Figure S3B), suggesting that ob-
served differences in mRNA quantity were not due to in-
efficient amplification by different primer sets. mGluR4
mRNA was present in the positive and negative fractions
of secondary neurospheres fluorescence activated cell
(FAC)-sorted for the NSC marker LeX [21] (Figure S3C),
indicating the receptor is present in progenitors as well
as more differentiated or committed cells. As a control,
the progenitor-specific marker nucleostemin [22] was cor-
rectly detected only in the LeX(+) fraction (Figure S3C). Ac-
cording to the Allen Brain Atlas (http://www.brain-map.
org/) [23], mGluR4 was expressed by a subset of cells
within the subventricular zone proximal to the lateral ven-
tricles (one of two neurogenic germinal zones within the
adult brain [24]; Figure S3D), as shown by nonisotopic
in situ hybridization. A specific probe for mGluR8 did not
detect any positive cells within this region (Figure S3D).
Thus, mGluR4 expression patterns suggest an important
role for this receptor in mediating neural progenitor prolif-
eration.Chemistry & Biology 14, 1019–1030To confirm that mGluR4 is the target of P-Ser for pro-
genitor proliferation, we used a loss-of-function approach
by RNA interference. Two siRNAs (Supplemental Experi-
mental Procedures) were designed to target mGluR4;
both effectively reduced mGluR4 mRNA levels (Fig-
ure 4D). Dissociated primary spheres were transfected
with mGluR4 siRNA versus control siRNA and replated
to form secondary spheres in the presence of either
P-Ser or vehicle. As shown in Figure 4E, although P-Ser
inhibits proliferation of cells transfected with control
siRNA (as expected), this inhibition by P-Ser is lost in
mGluR4 knockdown cells, indicating that the effect of
P-Ser is indeed mediated through mGluR4. Interest-
ingly, we found that mGluR4 knockdown produced
larger spheres than control cells (Figure 4E), suggesting
that mGluR4 may serve to restrict neural progenitor
growth. Consistent with this hypothesis, mGluR4 knock-
down led to hyperactivation of mTOR, a major regulator
of cell growth and proliferation [25], as indicated by
the greatly elevated levels of phospho-S389 S6K1
(Figure 4F).
We then tested the effects of mGluR4 knockdown on
neuronal differentiation. Following transfection with con-
trol or receptor-specific siRNAduplexes, progenitorswere
differentiated in the absence or presence of P-Ser. As
expected, cells transfected with control siRNA generated
more Tuj1+ cells when treated with P-Ser (Figure 5A). Con-
sistent with previous results, knockdown of mGluR4, September 2007 ª2007 Elsevier Ltd All rights reserved 1023
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A Phenotypic Screen for NeurogenesisFigure 4. The Effects of P-Ser Are Mediated by Metabotropic Glutamate Receptor 4
(A) Histogram of secondary sphere sizes; cells were plated at 1 k/ml and grown untreated or with 10 mM P-Ser, 20 mM L-AP4, 15 mM UBP1112, or
10 mM P-Ser + 15 mM UBP1112.
(B) P1 secondary cortical spheres, differentiated untreated or with 20 mM L-AP4, 10 mM P-Ser, 10 mM P-Ser + 15 mM UBP1112, or 15 mM UBP1112,
then stained for Tuj1 expression. Ctrl versus L-AP4, p = 0.0034; Ctrl versus P-Ser, p = 0.0041; P-Ser versus P-Ser + UBP, p = 0.0065. Presented as
mean ± SEM.
(C) RT-PCR analysis of group III metabotropic glutamate receptor expression in primary (1) and secondary (2) neurospheres, and postnatal day 8
mouse brain (P8; positive control). The retina-specific mGluR6 was not detected in any experiments (data not shown). –RT, no reverse transcriptase.
(D) RT-PCR analysis of cells transfected with negative control siRNA (siNC) or duplexes targeting mGluR4 (simGluR4).
(E) Histogram of neurosphere size following transfection with siNC or simGluR4 and treatment with water or 10 mM P-Ser. Similar results were
obtained with both duplexes; for clarity, only results from duplex 2 (simGluR4-2) are shown.
(F) Western blot analysis of E12.5 adherent progenitors cultured for 3 days posttransfection with either siNC, simGluR4-1, or simGluR4-2, or no
transfection (NT).
(G) Chemical structures of L-serine, P-Ser, L-glutamate, L-AP4, and UBP1112.abrogated the effect of P-Ser on neuronal differentiation
(Figure 5A). Interestingly, we consistently observed an
increase in O4+ cells under the receptor knockdown
conditions, regardless of P-Ser treatment (Figures 5B
and 5C). These data show that mGluR4 mediates the
effects of P-Ser on neuronal differentiation and also sug-
gests an unexpected role for mGluR4 in oligodendrocyte
differentiation.1024 Chemistry & Biology 14, 1019–1030, September 2007 ª2The experiments described above suggest that treat-
ment with P-Ser provides a simple method to enhance
neuronal production from mouse neural progenitors. To
determine whether such is also the case for human neural
progenitors, and to investigate potential therapeutic appli-
cation of these studies, we determined the effects of P-Ser
on differentiating neural progenitors derived from human
embryonic stem (hES) cells. As shown in Figures 6A–6C,007 Elsevier Ltd All rights reserved
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A Phenotypic Screen for NeurogenesisFigure 5. mGluR4 Mediates the Effects of P-Ser on Differentiation
(A) mGluR4 knockdown abolishes P-Ser-induced neuronal differentiation. E12 progenitors were transfected with negative control siRNA (siControl) or
duplex targeting mGluR4 (simGluR4) and differentiated for 3 days in the absence or presence of 20 mM P-Ser, and stained for Tuj1. siCtrl untreated
versus siCtrl P-Ser, p = 0.0018; siCtrl P-Ser versus simGluR4 P-Ser, p = 0.0021.
(B) mGluR4 knockdown increases oligodendrocyte differentiation. Cells were treated as in (A) and stained for the oligodendrocyte marker O4. siCtrl
untreated versus simGluR4 untreated, p = 0.0374; siCtrl P-Ser versus simGluR4 P-Ser, p = 0.0184.
(C) E12 progenitors transfected with siControl or simGluR4, differentiated in the absence of P-Ser, and stained for Tuj1 (green) and O4 (blue), counter-
stained with propidium iodide (red). The scale bars represent 50 mm.
Data are represented as mean ± SEM in (A) and (B).treatment with P-Ser doubled the number of neurons pro-
duced from two hES cell lines, HSF-1 (National Institutes
of Health [NIH] UC01; karyotype XX) and HSF-6 (NIH
UC06; karyotype XY). These results demonstrate that the
neurogenic effects of P-Ser are neither species nor gender
specific, and thus should prove broadly useful in directing
hES cells for neural regeneration.
DISCUSSION
In this paper, we describe high-throughput screening us-
ing primary cells to identify small molecules that regulate
complex phenotypes. There are clear advantages in being
able to use primary cells from animals of defined genetic
makeup and developmental stage, as well as patient-
derived cells, as opposed to cell lines that may contain un-
known genetic abnormalities or adaptations. We utilized a
simple method for the propagation of multipotent neural
progenitors that yielded reliable and reproducible data.
This culture system has proven invaluable for determining
the roles of both cell-intrinsic and extrinsic regulators (i.e.,
PTEN, LIF, and BMPs) of NSC proliferation, commitment,
and differentiation [26–29].
When dissected neural tissue is plated as single cells
under nonadherent, permissive conditions, floating balls
of cells termed neurospheres [9] are formed. These highlyChemistry & Biology 14, 1019–1030heterogeneous structures contain neural stem cells as
well as more restricted (i.e., bi- and unipotent) progenitors
anddifferentiated progeny. The presence of stemcells can
be confirmed by dissociating these neurospheres into sin-
gle cells and replating them. A small percentage (generally
3%) of these cells will re-form neurospheres, demon-
strating self-renewal. Multipotency of all of these spheres
can be determined post hoc, by differentiating them and
performing immunocytochemistry for common markers
of all three lineages.
To truly test the self-renewal potential of cells within the
neurosphere cultures, dissociated single cells need to be
plated at a density at which a single cell gives rise to a
single neurosphere. This is termed clonal analysis, and
recent reports [13, 30] have demonstrated that, when cul-
tured together under medium to high cell densities, small
neurospheres can adhere to each other and combine to
form larger neurospheres. Clonal analysis is impossible
under these conditions, and the true proliferative capacity
of the cells cannot be determined.
We have previously determined culture conditions
which allow for true clonal analysis [14]. Neural stem cells
from GFP+ animals were dissected and mixed with com-
parable cells from a wild-type animal, and the resulting
mixture was plated at varying cell densities. These differ-
ent cell densities were then analyzed for the presence of, September 2007 ª2007 Elsevier Ltd All rights reserved 1025
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A Phenotypic Screen for NeurogenesisFigure 6. P-Ser Increases Neuronal Differentiation of Human Embryonic Stem Cells
(A) Human embryonic stem cell-derived neural progenitors (hES-NPCs) derived from line HSF-1 were differentiated with or without 10 mM P-Ser for
6 days, then stained for Tuj1 expression. Left panels: Tuj1, green; right panels: Tuj1, green; propidium iodide, red. The scale bars represent 100 mm.
(B) hES-NPCs derived from line HSF-1 were differentiated as above and the percentage of Tuj1+ cells was determined, p = 0.000862.
(C) hES-NPCs derived from line HSF-6 were differentiated as above and the percentage of Tuj1+ cells was determined, p = 0.0158. Data are repre-
sented as mean ± SEM.chimeric neurospheres. Under high-density conditions,
nearly all spheres contained both GFP+ and GFP
spheres,mirroring the results of Singec et al. [13] and Jess-
berger et al. [30]. However, no chimeric neurospheres
were observed at a low cell density of 1000 cells/ml. We
have recently reconfirmed these data, observing <5%
chimeric neurospheres when cells were plated at 1000
cells/ml in 96-well plates (T.K.K. and H.I.K., unpublished
observations). These results are important for proper
interpretation of the clonal analysis and sphere size data
reported here (although not for the primary screen, which
was performed at high density).
In our initial screen, we utilized neurospheres passaged
one time to assay for cell differentiation and/or fate com-
mitment effects. These neurospheres contained very few
differentiated cells, as judged by TuJ1 immunocytochem-
istry (Figure 2E and data not shown), at the time they were
exposed to the chemical libraries, ensuring that observed
effects were not due to the presence of neurons that were
present at the time of initial culturing. It is important to note
that this screen does not require that each neurosphere is
derived from a single stem or progenitor cell. Furthermore,
the general methodology described here is widely applica-
ble. As effects on differentiation were determined via
antibody-based detection [31], this assay should be easily
adaptable to studying any process of interest so long as
one has a suitable antigenic marker. This methodology is
highly advantageous for screensutilizingdelicatecell types
such as primary culture stem cells (although nearly any cell
type may be used); specifically, no genetic manipulation,
such as introduction of a reporter gene, is necessary.1026 Chemistry & Biology 14, 1019–1030, September 2007 ª2Here we show that our method has great potential for
drug discovery and functional studies. Specifically, we
identified the orphan ligand P-Ser as a neurogenic en-
hancer, and established group III metabotropic glutamate
receptor 4 as its target. Metabotropic glutamate receptors
are generally located presynaptically, where they act to
modulate neuronal excitability and play roles in learning
and memory, depression, and other behaviors [32]. Re-
cent reports have demonstrated a role for group I (Gq-
linked) and II (Gs-linked) receptors in stem cell biology in
response to glutamate; mGluR3 and 5 have been shown
to promote proliferation of embryonic stem cells [33] and
neural stem cells [34, 35], and a positive role in neural
stem cell proliferation has been suggested for group II re-
ceptors in response to high extracellular concentrations of
glutamate [36]. We found a negative role for group III re-
ceptors (Gi-linked) in inhibiting neural stem cell/progenitor
proliferation and in enhancing neuronal survival. mGluR4
has previously been shown to inhibit proliferation of unipo-
tent cerebellar granule cell precursors [37]; in contrast to
this report, we highlight effects of activation of this recep-
tor by an endogenous ligand which act together to regu-
late proliferation, self-renewal, and neuronal lineage com-
mitment of multipotent progenitors, as well as survival of
their differentiated progeny, derived from multiple devel-
opmental time points.
Our data support the hypothesis that neural progenitor
proliferation, cell fate, and terminal cell differentiation
and survival are coupled. For example, we and others
have demonstrated that the phosphatase PTEN (phos-
phatase and tensin homolog deleted on chromosome 10)007 Elsevier Ltd All rights reserved
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as neuronal differentiation and survival [14, 29] (for a re-
view, see [38]). Others have shown that the length of the
neural progenitor cell cycle is directly coupled to cell-
fate choices, as factors that shorten the cell cycle inhibit
differentiative divisions, whereas those that lengthen the
cell cycle promote differentiative divisions [39]. Thus, the
data presented here are consistent with a model whereby
mGluR4 activation by P-Ser promotes neurogenesis
through enhanced neurogenic commitment (possibly a re-
sult of increased expression of bHLH transcription factors;
Figures 1F and 2F) by slowing progenitor proliferation.
As mentioned above, BMP, LIF, Wnt, PTEN/PI3K-Akt,
and other signaling events act to regulate NSC prolifera-
tion and differentiation. Known downstream effectors of
these regulators include the MAPK, STAT, and mTOR
pathways (which display extensive crosstalk) [40–42].
PTEN is a negative regulator of the PI3K-Akt-mTOR path-
way [42]. Activation of Akt results in enhanced neural
progenitor proliferation [43], neuronal differentiation [44],
and neuronal survival [45]. Treatment with rapamycin, an
mTOR inhibitor, results in decreased neurosphere forma-
tion [43]. Consistent with these observations, we found
that, in addition to abrogating the effects of P-Ser, siRNA
knockdown of mGluR4 also results in a large enhance-
ment of mTOR activity (Figure 4F). This is likely due to loss
of constitutive (ligand-dependent) activity upon receptor
knockdown. Although P-Ser enhances neuronal differenti-
ation and survival, activation of mGluR4 by P-Ser moder-
ately inhibits Akt and mTOR activity (data not shown). The
nature of this complexity could arise from differential acti-
vation thresholds for these processes, disparate effects
of divergent downstream effectors, modulation by unex-
amined pathways, or other possibilities.
Although the neurogenic activity of P-Ser was discov-
ered in vitro, this molecule likely has direct relevance for
in vivo neurogenesis. The ‘‘phosphorylated’’ serinebiosyn-
thetic pathway seems to be the main mechanism through
which the brain manufactures L-serine. The enzyme 3-
phosphoglycerate dehydrogenase (3-PGDH) catalyzes
the unidirectional production of a pyruvate intermediate,
which is furthermetabolized to P-Ser by phosphohydroxy-
pyruvate aminotransferase. P-Ser is then irreversibly de-
phosphorylated by phosphoserine phosphatase (PSP) to
formL-serine (for adiscussion, see [46]). 3-PDGH is specif-
ically expressed by radial glia and the astrocytes derived
from them [47]. Furthermore, genetic deletion of 3-PGDH
results in midembryonic lethality accompanied by severe
neurodevelopmental defects [16]. PSP was identified by
a genetic screen to be differentially expressed in neural
progenitors versus their differentiated progeny [48], and
is expressed in the germinal zones during embryonic and
postnatal development [49].
Provocatively, PSP is specifically expressed by GFAP-
expressing progenitors within the subventricular zone (a
region of ongoing adult neurogenesis [24]) and is present
in only a subset of 3-PGDH-expressing cells within this
area [50]. This suggests that whereas many cells within
the neurogenic regions may synthesize P-Ser, only someChemistry & Biology 14, 1019–103of these cells are capable of further metabolizing it to
L-serine and removing P-Ser from their local microenvi-
ronment. Following along this reasoning, P-Ser may be
released and then act in an autocrine or paracrinemanner,
whereas PSP-expressing cells may be able to ‘‘avoid’’
P-Ser’s effects by converting it to L-serine. Furthermore,
as P-Ser has 10- to 100-fold higher potency for mGluR4
than glutamate [51] and is active only at group III (but not
at group I or II) receptors [17], a model can be envisioned
where interplay between P-Ser and glutamate contributes
to drive neural progenitor behavior in vivo.
The identification of this P-Ser/mGluR4 pathway has
implications not only for neural development but also for
neural repair. A great deal of effort has been invested in
identifying methods of efficient neuronal production from
both embryonic and neural stem cells, in vitro and in vivo.
In the current study, we demonstrate that P-Ser treatment
dramatically enhances neuronal production from human
embryonic stem cells, aswell as frommurine CNS-derived
neural progenitors, making it a highly cost-effective re-
agent to potentially ‘‘prime’’ transplantable cells for differ-
entiation toward a neuronal cell fate. These studies also
raise the possibility that P-Ser or other mGluR4 effectors
could be used to promote neurogenesis following stroke
or other focal CNS injury.
Surprisingly, we also found a potential role for mGluR4
in oligodendrocyte differentiation. In mGluR4 knockdown
cells, western blot analysis of Stat3 (another mTor sub-
strate [52]) revealed the presence of lower molecular
weight bands (Figure S4), similar to those previously
shown to arise through proteolytic cleavage of Stat3 me-
diated by nonapoptotic caspase activity [53, 54]. As Stat3
signaling is important in astrogliogenesis [55], regulated
degradation of Stat3 in mGluR4 knockdown cells may
promote generation of oligodendrocytes at the expense
of astrocytes, although the details of this mechanism are
currently under investigation.
In summary, we have demonstrated a powerful, easily
adaptable, and robust method to screen molecular librar-
ies for compounds that enhance neuronal production from
ex vivo stem and progenitor cells. This method was used
to identify P-Ser (phosphoserine), an endogenous serine
metabolite, as a regulator of neural stem cell proliferation
and differentiation. Use of P-Ser as a tool to probe these
processes at the molecular level led to the identification
of metabotropic glutamate receptor 4 as the mediator of
P-Ser effects, and revealed a novel role for this receptor
in neural stem cell biology.
SIGNIFICANCE
Neural stemcells (NSCs) are capable of producing new
neurons, and are thus of great interest to those study-
ing the means to repair the central nervous system.
Enhancing the generation of neurons from NSCs is
an important therapeutic goal, and an understanding
of themechanisms bywhich neural stem cells prolifer-
ate and produce neurons will be critical to these ef-
forts. Small molecules that regulate neural stem cell0, September 2007 ª2007 Elsevier Ltd All rights reserved 1027
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as tools for exploring and controlling the mechanisms
underlying these processes, and could serve as candi-
date lead compounds for therapy of a variety of disor-
ders including stroke and spinal cord injury. Here we
report the development of a chemical genetic screen
using cells isolated from embryonic mouse forebrain.
We used this screen to identify the orphan ligand
phosphoserine (P-Ser) as a regulator of NSC differen-
tiation. P-Ser inhibits NSC proliferation and promotes
survival of nascent neurons. P-Ser also promotes neu-
ronal differentiation of human embryonic stem cell-
derived neural stem cells. Thus, P-Ser has potential
therapeutic value in addition to its basic utility as a
probe for dissecting molecular mechanisms underly-
ing neurogenesis.
This endogenous amino acid metabolite is a ligand
for group III metabotropic glutamate receptors
(mGluRs), and we show that the group III mGluR4 sub-
type mediates the effects of P-Ser on NSC prolifera-
tion and differentiation (a previously unknown role
for mGluR4). Furthermore, we found that the effects of
mGluR4 are mediated, at least in part, via the mTor
pathway, a pathway known to mediate neural stem
cell proliferation and neuronal survival. The current
findings not only specifically establish a role for P-Ser
and mGluR4 in neural stem cell biology but also dem-
onstrate the potential usefulness of cell-based chem-
ical genetic screens to identify molecules for use in
both basic and translational neural stem cell research.
EXPERIMENTAL PROCEDURES
Small-Molecule Screen
Four days after passaging primary spheres to single cells, the resultant
secondary spheres were resuspended in differentiation media (750
spheres in 200 ml) and cultured inwhite 96-well plates (Corning Life Sci-
ences, Corning, NY, USA) coated with 10 mg/ml poly-L-lysine (Sigma-
Aldrich, St. Louis, MO, USA). Libraries of orphan ligands and kinase/
phosphatase inhibitors were obtained fromBiomol (PlymouthMeeting,
PA, USA). Compounds were transferred to assay plates using 96-pin
replicators (Genetix Limited, Hampshire, UK). Spheres were incubated
for 3 days and used for antibody probing. Antigen detection was sim-
ilar to cytoblotting protocols [31, 56], with the following modifications.
Following incubation with Tuj1 antibody (1:500; Covance, Princeton,
NJ, USA) overnight at 4C, HRP-conjugated goat anti-mouse second-
ary antibody (Pierce, Rockford, IL, USA) was added for 2 hr at room
temperature, and chemiluminescence was developed with Supersig-
nal ELISA Pico substrate (Pierce). Signal was quantified on a plate
reader (Analyst HT; Molecular Devices, Sunnyvale, CA, USA).
Human Embryonic Stem Cell Culture
hESC lines HSF6 (46, XX) and HSF1 (46, XY) were maintained in irradi-
ated CF1 mouse embryonic fibroblast (MEF) cells in high-glucose
DMEM supplemented with 1 mM L-glutamine, 1% nonessential amino
acids, 0.1 mM b-mercaptoethanol, and 20% knockout serum replace-
ment (all from Invitrogen, Carlsbad, CA, USA). Culture medium was
changed and supplemented with 10 ng/ml bFGF daily. Confluent
hESC cultures were passaged weekly by incubation in 1 mg/ml dis-
pase/collagenase IV (Invitrogen) for 20 min at 37C.
For directed differentiation into neural progenitor cells (NPCs),
hESCs were passaged onto dishes coated with Matrigel (1:10 dilution;
BD Biosciences, San Jose, CA, USA) in the absence of irradiated1028 Chemistry & Biology 14, 1019–1030, September 2007 ª2MEFs. hESC medium was replaced with NPC medium (DMEM/F12
with B27 supplement and 500 U/ml penicillin/streptomycin, all from
Invitrogen) 4 days after passaging. Partially differentiated hESCs
were cultured for an additional 4 days, on Matrigel, in NPC medium
with daily addition of 10 ng/ml bFGF. hESC-NPCs were then continu-
ously passaged mechanically and cultured on PO/FN-coated culture
dishes (polyornithine and fibronectin; Sigma-Aldrich). For differentia-
tion of hESC-NPCs, cells were washed with Dulbecco’s PBS, and
fresh NPC medium, without bFGF, was added. Cells were incubated
for 6 days, with one intermediate medium change. P-Ser (20 mM)
was added to appropriate wells. The UCLA Institutional Review Board
has approved all experiments involving hESCs.
Other procedures are described in the Supplemental Data.
Supplemental Data
Supplemental Data include four figures, one table, and Supplemental
Experimental Procedures and are available at http://www.chembiol.
com/cgi/content/full/14/9/1019/DC1/.
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